The recommendation helps move the vaccine along the path into the commercial market, the report said.
The group at risk for mpox includes gay, bisexual and other men who have sex with men and transgender or nonbinary people who in the past six months meet one or more of four criteria: a new diagnosis of one or more sexually transmitted diseases; more than one sex partner; sex at a commercial sex venue; or sex linked to a large public event in a geographic region where mpox transmission is occurring. The recommendation also covers sexual partners of the risk group and those who anticipate experiencing any situation that would raise their risk.
The Advisory Committee for Immunization Practices also unanimously approved adding mpox vaccine to the Vaccines for Children program, and a trial is underway to determine the effectiveness and safety in children ages 12 to 17.
The recommendation moves to the CDC director for final approval.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
